阿维A治疗严重类型银屑病临床疗效

Clinical efficacy of Avi A on serious type of psoriasis

目的：观察阿维 A 治疗严重类型银屑病的临床疗效。方法选取2012年9月至2014年9月82例严重类型银屑病患者，包括22例寻常斑块型，20例红皮病型，19例泛发性脓疱型及21例关节病型，分别将其标记为 A、B、C、D 四组，观察并记录阿维 A 对这四组患者的治疗效果。结果 A 组治疗的总有效率为90.91％，B 组为85.00％，C 组为100.00％，D 组仅为52.38％；不良反应症状包括口干、唇炎、皮肤干燥、瘙痒以及脱发等，但经对症治疗，不良反应症状均消失。结论阿维 A 治疗严重类型银屑病临床疗效显著，值得推广与应用。

Objective To observe the clinical efficacy of Avi A on severe type of psoriasis. Methods Selected 82 cases of severe types of psoriasis patients from September 2012 to September 2014,including 22 cases of unusual plaque,20 cases of erythrodermic,19 cases pustular and 21 cases of type joints disease,respectively marked as A,B,C,D group. Observed and recorded the clinical effica-cy. Results The total effective rate of group A was 90. 91% ,and 85. 00% in group B,100. 00% in group C,and 52. 38% in group D. The adverse symptoms included dry mouth,cheilitis,dry skin,itch-ing and hair loss,but after symptomatic treatment,the adverse symptoms disappeared. Conclusions The clinical effect of Avi A on severe psoriasis is significant,and is worthy of promotion and application.